MedTrace Logo

Optimisation and Quantification of Contrast Enhanced Computed Tomography Myocardial Fibrosis Imaging

NCT02364687 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-06-27

No results posted yet for this study

Summary

Detecting scarred heart muscle is important to diagnose and treat of a wide variety of heart conditions. Magnetic resonance imaging (MRI) can assess scarred heart muscle but it is time consuming, contraindicated for some patients and not tolerated by others. Computed tomography (CT) imaging has the potential to provide a rapid comprehensive assessment of the heart. This study will assess CT imaging of the heart muscle of patients who have previously undergone MRI of their heart. Using a state of the art CT scanner the investigators will develop a low radiation dose protocol to identify scarred heart muscle. The investigators will use and develop software techniques to analyse these images. This will enable us to develop a new way to identify and measure scarred heart muscle that will benefit patients with heart disease.

Conditions

Interventions

RADIATION

Computed tomography late enhancement imaging

Sponsors & Collaborators

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • Michelle Williams · University of Edinburgh, NHS Lothian

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2015-12-31
Completion
2023-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02364687 on ClinicalTrials.gov